Drawing for EXELTIS

USPTO serial 79111421

EXELTIS

Reviewed by CopyMark Law Group

Reg. 4594815Status 706Registered
Filing date
Status date
Registration date
Sep 2, 2014
Examiner
STRUCK, ROBERT J
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with EXELTIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Arturo Perez-Guerrero

Arturo Perez-Guerrero PEREZ GUERRERO LLCP.O. Box 9024163San Juan, PR 00902-4163United States

Goods and services

ClassDescriptionStatusFirst use
005[ Pharmaceutical preparation for use in treating * ] Pharmaceutical preparations for the treatment of [ ophthalmic diseases and disorders, dermatological diseases and disorders, * digestive diseases and disorder, ] gynecological diseases and disorders, hormonal diseases and disorders [, blood disorders, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, * genitourinary disorders, * immunologic diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders, neurological diseases, psychiatric diseases, central nervous system, * ; pharmaceutical preparations for the treatment of diseases of the * musculoskeletal system, * diseases of the * respiratory system, circulatory system, * circulatory diseases, * viral diseases, glaucoma, dental and oral * mouth * diseases, headaches, migraine, obesity, hepatic treatments, * treatment of the liver; * cholesterol, blood pressure and rheumatic treatments; veterinary preparation for treating digestive diseases and disorder, gynecological diseases and disorders, blood disorders, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, immunologic diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders, neurological diseases, central nervous system, musculoskeletal system, respiratory system, circulatory system, viral diseases, glaucoma, dental and oral diseases, headaches, migraine, obesity, hepatic treatments, cholesterol, blood pressure and rheumatic treatments; and dietetic foods adapted for medical use, namely, breads, pastas, crackers, chips, snack foods, packaged meals, nutritional food bars, sweets, dips, sauces and food supplements in pill, powder, capsule, beverage form, effervescent tablet and liquid form * ; none of the aforesaid products are preparations in connection with neuroscience, including dementia, Alzheimer's disease and Parkinson's disease * ]ACTIVE—
010[ Surgical apparatus and instruments; [ medical instruments for use in gynecological and respiratory disorders; ] *medical instruments for gynecological disorders, ophthalmic disorders, dermatological disorders, metabolic and respiratory disorders; * orthopedic devices for diagnostic and therapeutic use; suture materials ]SECTION 71 - CANCELLED—
035[ Sales promotion for third parties, business management assistance; consulting on business management and marketing studies; presentation of goods on communication media, for retail purposes; business administration of product licenses and services for others; ] organization of exhibitions, trade fairs or congresses for business or advertising purposes, all relating to pharmaceutical, veterinary and biotechnological companies and for pharmaceutical, veterinary and biotechnological products *, but none of the aforesaid goods relating to neuroscience, including dementia, Alzheimer's disease and Parkinson's disease or to goods in the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease *ACTIVE—
042[ Chemical, biological and pharmaceutical research services; engineering * all * none * the aforesaid goods relating to the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease * ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 12, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 29, 2026NA15SEC. 15 ACKNOWLEDGEMENT - E-MAILED—
Oct 29, 202615AKREGISTERED - SEC. 15 ACKNOWLEDGED—
Oct 19, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 9, 2026E15RTEAS SECTION 15 RECEIVED—
Sep 19, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 19, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 19, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 5, 2025INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Apr 7, 2025INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Aug 7, 2024NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Aug 7, 202471AGREGISTERED-SEC.71 ACCEPTED—
Aug 7, 2024ES71TEAS SECTION 71 RECEIVED—
Sep 2, 2023REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Mar 24, 2022RNWLINTERNATIONAL REGISTRATION RENEWED—
Sep 19, 2021INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Aug 20, 2021INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Aug 20, 2021INPCINVALIDATION PROCESSED—
Aug 9, 2021INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 9, 2020NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Dec 9, 202071.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Dec 8, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 2, 2020ES71TEAS SECTION 71 RECEIVED—
Sep 2, 2019REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Sep 14, 2018INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Feb 28, 2018LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Oct 26, 2017COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Oct 26, 2017LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Oct 23, 2017CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Oct 6, 2017LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Sep 22, 2017CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Sep 21, 2017LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Mar 30, 2017INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Mar 30, 2017INPCINVALIDATION PROCESSED—
Mar 11, 2017INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jul 1, 2016LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
Jul 1, 2016COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Dec 18, 2015LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Dec 19, 2014FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 3, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 3, 2014FIMPFINAL DISPOSITION PROCESSED—
Dec 2, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 2, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 29, 2014TMBNTTAB RELEASE CASE TO TRADEMARKS—
Jul 29, 2014OP.TOPPOSITION TERMINATED NO. 999999—
Jul 29, 2014OP.DOPPOSITION DISMISSED NO. 999999—
Jun 20, 2014RFNPREFUSAL PROCESSED BY IB—
May 19, 2014IRRFIRREGULARITY ON REFUSAL FROM IB—
May 8, 2014OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
May 6, 2014OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Mar 10, 2014OP.IOPPOSITION INSTITUTED NO. 999999—
Jan 24, 2014OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 3, 2013ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 13, 2013GPNXNOTIFICATION PROCESSED BY IB—
Nov 12, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 12, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 23, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 23, 2013OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 23, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 8, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 4, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 2, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 2, 2013ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Oct 2, 2013OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 13, 2013PBTQWITHDRAWN FROM PUB OTQR REQUEST—
Sep 3, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 23, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 22, 2013AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Aug 22, 2013AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Aug 22, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 22, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 9, 2013PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jul 24, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 24, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 23, 2013ALIEASSIGNED TO LIE—
Jul 22, 2013PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jul 18, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 18, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 18, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 18, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 18, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 18, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 21, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 20, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 20, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 19, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 19, 2012ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 19, 2012REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 7, 2012RFNTREFUSAL PROCESSED BY IB—
Jun 20, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 20, 2012RFRRREFUSAL PROCESSED BY MPU—
Jun 20, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 19, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 14, 2012DOCKASSIGNED TO EXAMINER—
May 1, 2012MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 27, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 26, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance